The FDA's approval of the first over-the-counter birth control pill, Opill, in the U.S. on Thursday is a "a game changer in terms of access," Dr. Julia Cron, chief of Obstetrics and Gynecology at NewYork-Presbyterian Lower Manhattan Hospital, told Axios.
But similar progress has buckled in the U.S. thanks to lengthy regulatory processes and limited research in reproductive heath, Dr. Raegan McDonald-Mosley, the CEO of reproductive wellbeing nonprofit of Power to Decide, said.
Opill was the first birth control pill to be considered by the FDA as an over-the-counter option, and it could now pave the way for more, McDonald-Mosley added.
Meanwhile, more pharmacists across the U.S. have gradually been allowed to prescribe birth control, eliminating additional trips to other providers — though still requiring an extra layer of approval.
Arizona this month joined two dozen states — including Delaware, Nevada and Washington — and Washington, D.C. in allowing pharmacists to prescribe birth control, according to the Guttmacher Institute.
NEW YORK, April 27, 2026 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP alerts investors in ImmunityBio, Inc. (NASDAQ: IBRX) of a pending securities class action naming a senior executive as an ind...